Compare PLRX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | PRPL |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.6M | 76.9M |
| IPO Year | 2020 | 2015 |
| Metric | PLRX | PRPL |
|---|---|---|
| Price | $1.13 | $0.33 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $2.67 | $0.65 |
| AVG Volume (30 Days) | ★ 437.4K | 251.6K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.97 | ★ 152.75 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $468,725,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $6.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.09 | $0.30 |
| 52 Week High | $1.95 | $1.26 |
| Indicator | PLRX | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 30.59 |
| Support Level | $1.12 | N/A |
| Resistance Level | $1.37 | $0.44 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 26.67 | 19.53 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.